Bio-Rad Laboratories Affirms FY2026 Sales Guidance of $2.506B-$2.596B vs $2.588B Est
Benzinga Newsdesk 7 hours ago
NewsGuidance
Bio-Rad Laboratories (NYSE:BIO) affirms FY2026 sales outlook from $2.506 billion-$2.596 billion to $2.506 billion-$2.596 billion vs $2.588 billion estimate.
Bio-Rad Laboratories (NYSE:BIO) affirms FY2026 sales outlook from $2.506 billion-$2.596 billion to $2.506 billion-$2.596 billion vs $2.588 billion estimate.